icon-folder.gif   Conference Reports for NATAP  
 
  EACS - 12th European AIDS Conference
November 11-14, 2009
Cologne, Germany
Back grey_arrow_rt.gif
 
 
 
Simplification with fixed-dose tenofovir-emtricitabine or abacavir-lamivudine in adults with HIV infection: meta-analysis of two randomised, non-inferiority trials BICOMBO and STEAL
 
 
  Reported by Jules Levin
12th EUROPEAN AIDS CONFERENCE/EACS. Cologne, Germany, November 2009
 
The full report of the data from the original presentations of these 2 studies:
 
STEAL Study: SIMPLIFICATION WITH FIXED-DOSE TENOFOVIR-EMTRICITABINE OR ABACAVIR ... David A Cooper1, Mark Bloch2, Allison Humphries1, Janaki Amin1, David Baker3, Sean Emery1, Andrew Carr on behalf of the STEAL study group ...
www.natap.org/2009/CROI/croi_44.htm
 
IAS, Sydney 2007: Efficacy and safety of NRTI's switch to tenofovir plus emtricitabine (Truvada) vs. abacavir plus lamivudine (Kivexa) in patients with virologic suppression receiving a lamivudine containing HAART: The BICOMBO study - (07/30/06)
 
Amin J1; De Lazzari E2; Emery S1; Humphries A1; Martinez E2; Carr A3; Gatell J2; Cooper DA1
on behalf of the BICOMBO and STEAL study teams
 
1. National Centre in HIV Epidemiology and Clinical Research University of New South Wales, Sydney, Australia
2. Hospital Clinic-IDBAPS- University of Barcelona, Barcelona, Spain
3. HIV, Immunology and Infectious Diseases Unit, St Vincent's Hospital, Sydney, Australia

image002.gif

image004.gif

image006.gif

image008.gif

image010.gif

image012.gif

image014.gif

image016.gif

image018.gif

image020.gif

image022.gif

image024.gif